Continued research into the precise mechanisms by which PDE4 contributes to the pathogenesis of NAFLD could lead to the development of novel treatment strategies aimed at mitigating liver injury and its associated systemic effects. This evidence concerns the gene PDE4A and metabolic dysfunction-associated steatotic liver disease.